Aston Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
– Sell
-3,819
Closed -$269K – 137
2015
Q2
$269K Sell
3,819
-133
-3% -$9.84K 0.13% 128
2015
Q1
$313K Sell
3,952
-16,534
-81% -$1.22M 0.14% 127
2014
Q4
$1.3M Sell
20,486
-1,510
-7% -$94.7K 0.55% 82
2014
Q3
$1.31M Sell
21,996
-152
-0.7% -$8.7K 0.31% 94
2014
Q2
$1.19M Buy
22,148
+276
+1% +$15.1K 0.27% 98
2014
Q1
$1.32M Sell
21,872
-7,095
-24% -$414K 0.31% 95
2013
Q4
$1.54M Sell
28,967
-4,936
-15% -$248K 0.38% 90
2013
Q3
$1.57M Sell
33,903
-7,859
-19% -$361K 0.43% 84
2013
Q2
$1.71M Buy
+41,762
New +$1.79M 0.48% 85

Other funds holding CRL

Aston Asset Management's CRL Position: Q3 2015 in Review

Aston Asset Management sold out of Charles River Laboratories (CRL) in Q3 2015, closing a stake of 3,819 shares — an estimated $269K sold.

Aston Asset Management first reported a position in CRL in Q2 2013 and held it in 9 quarters. The position peaked at $1.71M in Q2 2013. 258 funds tracked by Wall St. Rank hold CRL as of Q3 2015.

  • Aston Asset Management reported no remaining Charles River Laboratories position as of Q3 2015 after selling out during the quarter.
  • Aston Asset Management sold 3,819 Charles River Laboratories shares in Q3 2015, an estimated $269K.
  • Aston Asset Management first reported a position in Charles River Laboratories in Q2 2013 and held it in 9 quarters.
  • Aston Asset Management's Charles River Laboratories position peaked at $1.71M in Q2 2013.
  • 258 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2015.

Based on Aston Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.